The identification of effective biomarkers has becoming a major focus in cancer research, mainly due to the necessity of selecting potentially responsive patients in order to improve their outcomes, as well as to reduce the toxicity and costs related to ineffective treatments. In genitourinary tumors, the lack of biomarkers does not allow for the development of personalized strategies for a single patient, thus representing a major goal in this field. This Research Topic aims to include the description of these emerging techniques and identify the most promising biomarkers in genitourinary tumors.
The following themes will be covered:
1. An overview of tissue and liquid molecular biomarkers in genitourinary tumors
2. New prostate cancer targets for imaging and therapy
3. Recent advances in liquid biopsy in patients with castration-resistant prostate cancer
4. Updates on urine markers in superficial and non-superficial bladder cancer
5. Emerging biomarkers in bladder identified by network analysis of transcriptomic data
6. The identification of immunological biomarkers in kidney cancers
7. Future perspectives on molecular biomarkers in genitourinary tumors: towards a personalized approach to diagnosis, prognosis and prediction of response to therapy
The identification of effective biomarkers has becoming a major focus in cancer research, mainly due to the necessity of selecting potentially responsive patients in order to improve their outcomes, as well as to reduce the toxicity and costs related to ineffective treatments. In genitourinary tumors, the lack of biomarkers does not allow for the development of personalized strategies for a single patient, thus representing a major goal in this field. This Research Topic aims to include the description of these emerging techniques and identify the most promising biomarkers in genitourinary tumors.
The following themes will be covered:
1. An overview of tissue and liquid molecular biomarkers in genitourinary tumors
2. New prostate cancer targets for imaging and therapy
3. Recent advances in liquid biopsy in patients with castration-resistant prostate cancer
4. Updates on urine markers in superficial and non-superficial bladder cancer
5. Emerging biomarkers in bladder identified by network analysis of transcriptomic data
6. The identification of immunological biomarkers in kidney cancers
7. Future perspectives on molecular biomarkers in genitourinary tumors: towards a personalized approach to diagnosis, prognosis and prediction of response to therapy
